Detalhe da pesquisa
1.
Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma.
Oncologist
; 27(1): e18-e28, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305102
2.
Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location.
BMC Med Genomics
; 16(1): 289, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974218
3.
Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis.
Cancer Res Treat
; 55(2): 626-635, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550683
4.
M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study.
Front Oncol
; 13: 1139990, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969032
5.
Gene variation profile and it's potential correlation with clinical characteristics in HBV-associated HCC patients of Sichuan Han nationality in China.
Asian J Surg
; 46(10): 4371-4377, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894454
6.
Pedigree analysis of the EGFR p.V1010M germline mutation in a family with a family history of non-small-cell lung cancer.
Ann Transl Med
; 10(3): 154, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284553
7.
EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report.
Front Oncol
; 12: 1008932, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36338754
8.
Variation of the ileocolic artery and superior mesenteric artery in a patient with right-sided colon cancer with Lynch syndrome: a case report.
Ann Transl Med
; 10(17): 939, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172100
9.
Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers.
Front Immunol
; 13: 811601, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35265073
10.
Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
Ann Transl Med
; 10(16): 885, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36110997
11.
Case Report: Response to Almonertinib in a Patient With Metastatic NSCLC Resistant to Osimertinib due to Acquired EGFR L718Q Mutation.
Front Pharmacol
; 12: 731895, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987382
12.
The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC.
Front Oncol
; 11: 671963, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34336662
13.
The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review.
Ann Transl Med
; 9(22): 1703, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988212
14.
Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.
Front Oncol
; 11: 570241, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33628741
15.
Genetic Heterogeneity Between Paired Primary and Brain Metastases in Lung Adenocarcinoma.
Clin Med Insights Oncol
; 14: 1179554920947335, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32922114
16.
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis.
JAMA Oncol
; 6(3): 375-384, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876895
17.
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Clin Cancer Res
; 26(14): 3649-3661, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241817
18.
Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors.
J Thorac Oncol
; 15(4): 556-567, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843683
19.
Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing.
Front Pharmacol
; 10: 230, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930778
20.
Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.
J Evid Based Med
; 11(4): 278-287, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30444051